Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-28

Clinical Trial Update: Treatment of Patients With Idiopathic Membranous Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating treatment for membranous nephropathy has completed, according to the status update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Glomerulonephritis, Membranous | Phase 3 | Status: COMPLETED